Hartmut Schmidt

Active 1982–2025

136
Papers
19,334
Citations
67
h-index
128
i10-index

Citations

Citations per year for Hartmut Schmidt1985: 2 citations1986: 2 citations1988: 2 citations1989: 1 citations1991: 1 citations1992: 5 citations1993: 5 citations1994: 3 citations1995: 3 citations1996: 3 citations1997: 6 citations1998: 18 citations1999: 20 citations2000: 47 citations2001: 72 citations2002: 68 citations2003: 94 citations2004: 68 citations2005: 85 citations2006: 72 citations2007: 74 citations2008: 71 citations2009: 61 citations2010: 55 citations2011: 74 citations2012: 63 citations2013: 85 citations2014: 83 citations2015: 102 citations2016: 91 citations2017: 136 citations2018: 126 citations2019: 757 citations2020: 871 citations2021: 786 citations2022: 770 citations2023: 584 citations2024: 937 citations2025: 486 citations2026: 19 citations1987: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,051 citing papers, 22.9% of this breakdownGermany: 746 citing papers, 8.4% of this breakdownChina: 744 citing papers, 8.3% of this breakdownUnited Kingdom: 618 citing papers, 6.9% of this breakdownItaly: 539 citing papers, 6% of this breakdownFrance: 449 citing papers, 5% of this breakdownSpain: 290 citing papers, 3.3% of this breakdownJapan: 288 citing papers, 3.2% of this breakdownCanada: 281 citing papers, 3.2% of this breakdownNetherlands: 208 citing papers, 2.3% of this breakdownIndia: 186 citing papers, 2.1% of this breakdownAustralia: 179 citing papers, 2% of this breakdown
0%22.9%Other 26.4%

Fields

  • Biochemistry, Genetics and Molecular Biology45.2%
  • Medicine38.7%
  • Neuroscience5.8%
  • Nursing4.7%
  • Immunology and Microbiology1.3%
  • Engineering1.1%
  • Other3.2%

Topics

  • Amyloidosis: Diagnosis, Treatment, Outcomes5%
  • RNA Interference and Gene Delivery4.9%
  • Advanced biosensing and bioanalysis techniques2.8%
  • Liver Disease Diagnosis and Treatment2%
  • Liver Disease and Transplantation2%
  • Trace Elements in Health1.9%
  • Other81.4%

Coauthors

All papers

Open in search
  1. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, Jared Gollob, Ole B. Suhr - New England Journal of Medicine 2018 cited by 2,918

  2. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer J. Knox, Janine M. Davies, Jamil Asselah, Mayur Brahmania, Habeeb Majeed, Luis J. Villanueva-Rivera, Patricio Yañez Weber, Marcelo Garrido, Gonzalo Pizarro, Nicolás Yáñez, Ruocai Xu, Shuangyan Ou, Zhenggang Ren, Hongming Pan, Zhiqiang Meng, Kangsheng Gu, Xi Chen, Tao Zhang, Chunyi Hao, Peiguo Cao, Yabing Guo, Shukui Qin, Juxiang Xiao, Weijia Fang, Xin Wang, Yuxian Bai, Xiaoming Chen, Dong Yan, Hong Zhao, Jieer Ying, Carlos Bonilla, Olga Urrego, Ángela R. Zambrano, Mauricio Lema, Juan Carlos Restrepo, Andrés F. Cardona, Sandra Franco Millan, Madiedo Oscar, Víctor Ramos, Philippe Merle, Samuel Lesourd, Julien Edeline, Jean–Pierre Bronowicki, Marc Bourlière, Stéphane Cattan, Mohamed Bouattour, Laurent Mineur, Hélène Regnault, Barbara Dauvois, Kornelius Schulze, Gunnar Folprecht, Andreas Geier, Oliver Waidmann, Fabian Finkelmeier, Marino Venerito, Marie‐Luise Berres, Thomas Berg, Christian M. Lange, Hartmut Schmidt, Dirk Waldschmidt, Michael Bitzer, Ray McDermott, Austin G. Duffy, Gianluca Masi, Vittorina Zagonel, Giuseppe Tonini, Fabio Piscaglia, Stefania Gori, Mimma Rizzo, Elisa Biscaldi and 109 more - The Lancet Oncology 2023 cited by 421

  3. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiangtung W. Jung, Brenda F. Baker, Elizabeth J. Ackermann, Morie A. Gertz, Teresa Coelho - New England Journal of Medicine 2018 cited by 1,422

  4. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

    Authors: , - Advances in Therapy 2020 cited by 480

  5. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 267

  6. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

    Authors: , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2015 cited by 322

  7. Tafamidis for transthyretin familial amyloid polyneuropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2012 cited by 795

  8. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincenzo Rizzo, Massimo Russo, Anna Mazzeo, Luca Gentile, John L. Berk, Caitlin Brueckner, Victoria Lazzari, Janice F. Wiesman, Douglas DeLong, Jennifer Victory, James A. R. Dalton, John J. May, Catherine Gilmore, Shahram Attarian, Saran Diallo, Émilien Delmont, Jean Pouget, Annie Verschueren, Aude‐Marie Grapperon, Emmanuelle Salort‐Campana, Isabel Conceição, Ana Tarina Alvarez Lopes, Filipa Lamas, Carlos Marques‐Neves, José Castro, Pedro Pereira, Isabel Castro, Ana Franco, Miguel Oliveira Santos, Conceição de Azevedo Coutinho, Catarina Falcão de Campos, Teresa Coelho, Antonio Hipólito Reis, Nuno Correia, Javier Martínez Pérez, Ana Silva, Cristina Alves, Márcio Cardoso, Kátia Valdrez, Julia R Monte, Bernardete Pessoa, Nádia Guimarães, Mónica Freitas, Joana Ramalho, Natália Ferreira, Daisuke Kuzume, Céline Tard, Nawal Waucquier, Isabelle Rougeaux, Sylvie Brice, Emmanuelle Kasprzyk, Elise Elrezzi, Sayah Meguig, É. Hachulla, Clément Gauvain, Maria-Claire Migaud-Chervy, Dominique Deplanque, Elsa Jozefowicz, Loïc Lebellec, David B. Adams, Line Balaya-Gouraya, Nathalie Jehan Lacour, Halima Bournane, Nathalie Martin, Mongia Elabed, Niamey Sacko, Yasmine Boubrit, Amina Gaouar, Fetra Rakotondratafika, Marie Théaudin-Saliou and 345 more - The Lancet Neurology 2020 cited by 156

  9. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2012 cited by 561

  10. Superior Tumor Detection for68Ga-FAPI-46 Versus18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2023 cited by 63

  11. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 473

  12. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Geier, Florian P. Reiter, Bernhard Schlevogt, Juliana Gödiker, Wolf Peter Hofmann, Peter Buggisch, Julia Kahlhöfer, Kerstin Port, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer, Katja Deterding - JHEP Reports 2023 cited by 61

  13. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georg Lamprecht, Moises Sanchez, Rajeshwar P. Mookerjee, Andrew Davenport, Nathan Davies, Marco Pavesi, Fausto Andreola, Agustı́n Albillos, Jeremy Cordingley, Hartmut Schmidt, Juan Antonio Carbonell‐Asins, Vicente Arroyo, Javier Fernández, Steffen Mitzner, Rajiv Jalan - Journal of Hepatology 2023 cited by 68

  14. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2018 cited by 171

  15. Methanobactin reverses acute liver failure in a rat model of Wilson disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Zischka - Journal of Clinical Investigation 2016 cited by 164

  16. Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease

    Authors: , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2013 cited by 249

  17. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francisco Muñoz Beamud, David Adams, H. Moelgaard, Rayomand Press, Calogero Lino Cirami, Hans Nienhuis, Josep Maria Campistol Plana, Jocelyn Inamo, Daniel Jacoby, Michele Emdin, Dianna Quan, Scott L. Hummel, Ronald Witteles, Amir Dori, Sanjiv J. Shah, Daniel J. Lenihan, Olga Azevedo, Srinivas Murali, Saša Živković, Soon-Chai Low, José Nativi-Nicolau, Nowell M. Fine, José Tallaj, Carsten Tschöepe, Roberto Fernández‐Torrón, Michael Polydefkis, Giampaolo Merlini, Sorina Bădeliță, Stephen S. Gottlieb, James M. Tauras, Edileide Barros Correia, Hector Ventura, Burkhard Gess, Felix Darstein, Jeeyoung Oh, Tessa Marburger, Johan Van Cleemput, Valeria Salutto, Yeşim Parman, Chi‐Chao Chao, Nitasha Sarswat, Christopher R. Mueller, D. Eric Steidley, Jeffrey Ralph, Alberta L. Warner, William Cotts, James E. Hoffman, Marcelo Rugiero, Sonoko Misawa, J.L. Muñoz Blanco, Lucía Galán Dávila, Menachem Sadeh, Jin Luo, Theodoros Kyriakides, Annabel Wang, Horacio Kaufmann, Saša Živković - Orphanet Journal of Rare Diseases 2022 cited by 89

  18. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Joachim Mössner, Niels Teich, Miklós Sahin‐Tóth - Nature Genetics 2007 cited by 435

  19. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

    Authors: , , , , , , , , , , , , , - Journal of Neurology 2013 cited by 339

  20. “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy

    Authors: , , , , , , - Journal of the Peripheral Nervous System 2015 cited by 292

  21. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

    Authors: , , , , , , , , - Muscle & Nerve 2017 cited by 212

  22. Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshiki Sekijima, José Tallaj, Christopher R. Mueller, Johan Van Cleemput, Violaine Planté‐Bordeneuve, Hans Nienhuis, Dianna Quan, D. Eric Steidley, Hartmut Schmidt, Jonas Wixner, Michael Polydefkis, Jeffrey Ralph, Hector Ventura, Saša Živković, Burkhard Gess, Roberto Fernández‐Torrón, Stephen S. Gottlieb, William Cotts, James M. Tauras, Nitasha Sarswat, Juan González Moreno, Yeşim Parman, Jin Luo - Cardiology and Therapy 2022 cited by 47

  23. The Operating System of the Neuromorphic BrainScaleS-1 System

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neurocomputing 2022 cited by 29

  24. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Alejandra Gonzalez Duarte Briseno, Hans Nienhuis, Olga Azevedo, Josep Maria Campistol Plana, Juan González Moreno, José González‐Costello, Jonas Wixner, Yeşim Parman, Sanjiv J. Shah, Dianna Quan, Tessa Marburger, Michael Polydefkis, Stephen S. Gottlieb, Jeffrey Ralph, Nitasha Sarswat, Jin Luo, Srinivas Murali, William Cotts, Brian Drachman, D. Eric Steidley, Scott L. Hummel, David Slosky, Hector Ventura, Daniel Jacoby, James E. Hoffman, James M. Tauras, Saša Živković, José Tallaj, Daniel J. Lenihan, Christopher R. Mueller - JACC CardioOncology 2021 cited by 61